← All organizations
Highest phase reached
Phase 2
First clinical trial
Oct 24, 2017Last known activity
Apr 9, 2025
Timeline
No events for the selected filters.
Drugs by trial phase (11 distinct, 12 trials)
Phase 2 (10 own, 0 via acquisition)
Phase 1 (1 own, 0 via acquisition)
Indications
Studied for
Recent trials (12)
- NCT06956716CollaboratorPhase 1/Phase 2Apr 9, 2025
- NCT06995105CollaboratorPhase 1/Phase 2Apr 9, 2025
- NCT06888674CollaboratorPhase 1/Phase 2Apr 1, 2025
- NCT06888648CollaboratorPhase 1/Phase 2Apr 1, 2025
- NCT06026800CollaboratorPhase 1Sep 8, 2023
- NCT06019702CollaboratorPhase 1Sep 8, 2023
- NCT06026774CollaboratorPhase 1Sep 8, 2023
- NCT05307835CollaboratorPhase 1Dec 2, 2021
- NCT04810910CollaboratorPhase 1Mar 30, 2021
- NCT04864379CollaboratorPhase 1Sep 3, 2020
- NCT03662815CollaboratorPhase 1Feb 7, 2018
- NCT03645148CollaboratorPhase 1Oct 24, 2017
Details
- Last known activity
- Apr 9, 2025